Target intelligence / Profile preview

NBPF member 17, pseudogene (NBPF17P)

Target: NBPF17P
Molecular classification: Other, Pseudogene

Overview

NBPF member 17, pseudogene (NBPF17P) is a human pseudogene within the neuroblastoma breakpoint family (NBPF), located on chromosome 1. As a pseudogene, NBPF17P does not encode a functional protein and is not considered a therapeutic target such as a receptor, enzyme, or transporter. Diseases associated with this locus include neuroblastoma and microcephaly, although there is no evidence that the pseudogene has a direct, active biological function or known involvement in drug response or clinical biomarker roles[1][3][4][5][6][7][9].

Other names: NBPF23NBPF23Pneuroblastoma breakpoint family member 17, pseudogeneneuroblastoma breakpoint family, member 23, pseudogene

Disease associations

NeuroblastomaMicrocephaly

Beyond the preview

Go deeper on NBPF member 17, pseudogene (NBPF17P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NBPF member 17, pseudogene (NBPF17P).

Explore the full profile